Literature DB >> 17351808

Two cases of hepatopulmonary syndrome with improved liver function following long-term oxygen therapy.

Kazuko Y Fukushima1, Hiroshi Yatsuhashi, Akitoshi Kinoshita, Toshihito Ueki, Takehiro Matsumoto, Mitsuhiko Osumi, Yohjiro Matsuoka.   

Abstract

Hepatopulmonary syndrome (HPS) is a complication of liver disease that is characterized by hypoxemia and intrapulmonary vascular dilatations. The only established therapy for this disorder is liver transplantation. Here, we report two patients (a 63-year-old woman and a 72-year-old man) with HPS associated with hepatitis C virus-related cirrhosis. We gave the patients low-dose oxygen supplementation to improve their respiratory symptoms. Surprisingly, their liver function improved from Child Pugh class C to class A, and ascites disappeared after a year of oxygen supplementation. We believe that long-term oxygen therapy contributed to the improvement of liver function in these two cases. Long-term oxygen therapy might offer a new therapeutic approach to improve liver function in patients with cirrhosis with hypoxemia.

Entities:  

Mesh:

Year:  2007        PMID: 17351808     DOI: 10.1007/s00535-006-1965-0

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  15 in total

1.  The hepatopulmonary syndrome: new name, old complexities.

Authors:  R Rodríguez-Roisin; A G Agustí; J Roca
Journal:  Thorax       Date:  1992-11       Impact factor: 9.139

2.  Capillarization of hepatic sinusoids in man.

Authors:  F SCHAFFNER; H POPER
Journal:  Gastroenterology       Date:  1963-03       Impact factor: 22.682

Review 3.  The hepatopulmonary syndrome.

Authors:  P A Lange; J K Stoller
Journal:  Ann Intern Med       Date:  1995-04-01       Impact factor: 25.391

4.  The influence of hypoxia and hemorrhage upon adenylate energy charge and bile flow.

Authors:  M Ukikusa; T Ida; K Ozawa; T Tobe
Journal:  Surg Gynecol Obstet       Date:  1979-09

5.  Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis.

Authors:  Christophe Corpechot; Veronique Barbu; Dominique Wendum; Nils Kinnman; Colette Rey; Raoul Poupon; Chantal Housset; Olivier Rosmorduc
Journal:  Hepatology       Date:  2002-05       Impact factor: 17.425

6.  The effect of oxygen supplementation on the arterial ketone body ratio in human cirrhosis.

Authors:  Paul R Froomes; Hany Ghabrial; Denis J Morgan; Peter W Angus
Journal:  Digestion       Date:  2002       Impact factor: 3.216

Review 7.  Hepatopulmonary syndrome.

Authors:  David I Gaines; Michael B Fallon
Journal:  Liver Int       Date:  2004-10       Impact factor: 5.828

8.  Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis.

Authors:  Peter Schenk; Maximilian Schöniger-Hekele; Valentin Fuhrmann; Christian Madl; Gerd Silberhumer; Christian Müller
Journal:  Gastroenterology       Date:  2003-10       Impact factor: 22.682

9.  Diurnal fluctuations of arterial ketone body ratio in normal subjects and patients with liver dysfunction.

Authors:  S Iwata; K Ozawa; Y Shimahara; K Mori; N Kobayashi; K Kumada; Y Yamaoka
Journal:  Gastroenterology       Date:  1991-05       Impact factor: 22.682

10.  Hepatopulmonary syndrome. Clinical observations and lack of therapeutic response to somatostatin analogue.

Authors:  M J Krowka; E R Dickson; D A Cortese
Journal:  Chest       Date:  1993-08       Impact factor: 9.410

View more
  6 in total

Review 1.  Hepatopulmonary syndrome: What we know and what we would like to know.

Authors:  Israel Grilo-Bensusan; Juan Manuel Pascasio-Acevedo
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

Review 2.  Portopulmonary hypertension and hepatopulmonary syndrome.

Authors:  Florence Aldenkortt; Marc Aldenkortt; Laurence Caviezel; Jean Luc Waeber; Anne Weber; Eduardo Schiffer
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

Review 3.  Differential diagnosis of hepatopulmonary syndrome (HPS): Portopulmonary hypertension (PPH) and hereditary hemorrhagic telangiectasia (HHT).

Authors:  Inna Krynytska; Mariya Marushchak; Anna Mikolenko; Anzhela Bob; Iryna Smachylo; Ludmyla Radetska; Olga Sopel
Journal:  Bosn J Basic Med Sci       Date:  2017-11-20       Impact factor: 3.363

Review 4.  Cirrhosis and its complications: evidence based treatment.

Authors:  Salman Nusrat; Muhammad S Khan; Javid Fazili; Mohammad F Madhoun
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

Review 5.  Review article: Update on current and emergent data on hepatopulmonary syndrome.

Authors:  Stergios Soulaidopoulos; Evangelos Cholongitas; George Giannakoulas; Maria Vlachou; Ioannis Goulis
Journal:  World J Gastroenterol       Date:  2018-03-28       Impact factor: 5.742

6.  Development of severe intrapulmonary shunting in a patient with carcinoid heart disease after closure of a persistent foramen ovale: a case report.

Authors:  Dominik Schüttler; Konstantinos Mourouzis; Christoph J Auernhammer; Konstantinos D Rizas
Journal:  Eur Heart J Case Rep       Date:  2021-12-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.